Anti-arrhythmic medicines: a new prototype targeting the ryanodine channel (RyR2) to reduce sudden death in heart failure patients (2021–2023)

Grant type:
Prince Charles Hospital Foundation
Researchers:
Funded by:
The Prince Charles Hospital Foundation